Advances in Metastatic Castration Resistant Prostate Cancer (mCRPC) Management
- By Sonali Karhana - Despite recent diagnostic and therapeutic advances, prostate adenocarcinoma is the second most common cancer in the Western male population. One in 7 men over the age of 50 years are diagnosed with prostate cancer at some point in their lives. “The first step toward ending this disease, which takes the [...]